Tevogen Bio Holdings Inc. (TVGN) Stock Forecast
TVGN analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $2.00 average of analyst targets
- Upside to target
- −71.7% from the latest close
- Next earnings
- November 13, 2026 EPS estimate $-2.50
- 52-week range
- $3.89 – $387.50
TVGN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TVGN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (FY2026) | −$10.00 | −$10.00 | −$10.00 | −$8.08 | −23.8% | 1 |
| Next fiscal year (FY2027) | −$13.00 | −$13.00 | −$13.00 | −$10.00 | −30.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TVGN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (FY2026) | $0 | $0 | $0 | 0.0% | — |
| Next fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 1 |
TVGN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TVGN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (FY2026) | −$11.00 | −$11.00 | −$11.00 | −$11.00 | −$10.00 | −9.1% | 1 up · 0 down |
| Next fiscal year (FY2027) | $55.50 | $55.50 | $55.50 | $55.50 | −$13.00 | −123.4% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TVGN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TVGN beat in 3 of 5.
What analysts expect from TVGN
The average price target is $2.00, 71.7% below the latest close of $7.07. Analysts expect earnings of −$10.00 per share for FY2026, −23.8% from a year earlier. For FY2027 the average estimate is −$13.00 per share. Tevogen Bio beat the EPS estimate in 3 of the last 5 quarters.
Related: TVGN income statement, TVGN key metrics, TVGN chart. See the TVGN stock overview for the latest quote and news.
TVGN forecast FAQ
What is Tevogen Bio's price target?
The average analyst price target for Tevogen Bio is $2.00, 71.7% below the latest close of $7.07.
What is Tevogen Bio's EPS forecast?
Analysts forecast −$10.00 per share for FY2026 (range −$10.00 to −$10.00); for FY2027 the estimate is −$13.00.
When does Tevogen Bio report earnings?
Tevogen Bio is expected to report results for the quarter ending September 30, 2026 on November 13, 2026 after the market closes; the EPS estimate is $-2.50.
Does Tevogen Bio usually beat earnings estimates?
Tevogen Bio reported EPS at or above the analyst estimate in 3 of the last 5 quarters.